Zenas Biopharma Inc (ZBIO)

R&D Expense Growth

20.79%

Fiscal year · Period ending:

ZBIO logo

ZBIO R&D Expense Growth

Latest reported20.79%
ZBIO FY R&D Growth (YoY) (0.00% → 20.79%)
High-resolution chart · PNG

ZBIO r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Zenas Biopharma Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
20.7878%
131.7709%
-4.2368%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.